Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Belgian guidelines for economic evaluations: second edition.

Thiry N, Neyt M, Van De Sande S, Cleemput I.

Int J Technol Assess Health Care. 2014 Dec;30(6):601-7. doi: 10.1017/S0266462314000725.

PMID:
25816826
2.

Belgian guidelines for budget impact analyses.

Neyt M, Cleemput I, Sande SV, Thiry N.

Acta Clin Belg. 2015 Jan 11:2295333714Y0000000118. [Epub ahead of print]

PMID:
25579611
3.

Should chronic hepatitis B be treated as early as possible?

Hulstaert F, Schwierz C, Nevens F, Thiry N, Gamil M, Colle I, Van de Sande S, Horsmans Y.

Int J Technol Assess Health Care. 2013 Jan;29(1):35-41. doi: 10.1017/S0266462312000736. Epub 2013 Jan 8.

PMID:
23298548
4.

Calculating an intervention's (cost-)effectiveness for the real-world target population: the potential of combining strengths of both RCTs and observational data.

Neyt M, Cleemput I, Thiry N, De Laet C.

Health Policy. 2012 Jul;106(2):207-10. doi: 10.1016/j.healthpol.2012.04.014. Epub 2012 May 16.

PMID:
22608108
5.

Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions.

Cleemput I, Neyt M, Thiry N, De Laet C, Leys M.

Int J Technol Assess Health Care. 2011 Jan;27(1):71-6. doi: 10.1017/S0266462310001194. Epub 2011 Jan 25. Review.

PMID:
21262069
6.

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions.

Neyt M, Devriese S, Thiry N, Van den Bruel A.

BMC Pulm Med. 2010 Sep 15;10:47. doi: 10.1186/1471-2466-10-47.

7.

Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.

Cleemput I, Thiry N.

Pharmacoeconomics. 2009;27(5):433; author reply 433-4. doi: 10.2165/00019053-200927050-00008. No abstract available.

PMID:
19586082
8.

Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.

Thiry N, De Laet C, Hulstaert F, Neyt M, Huybrechts M, Cleemput I.

Int J Technol Assess Health Care. 2009 Apr;25(2):161-70. doi: 10.1017/S0266462309090217.

PMID:
19366497
9.

Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context.

Neyt M, Thiry N, Ramaekers D, Van Brabandt H.

Appl Health Econ Health Policy. 2008;6(1):67-80.

PMID:
18774871
10.

Introduction of emerging medical devices on the market: a new procedure in Belgium.

Vinck I, Neyt M, Thiry N, Louagie M, Ramaekers D.

Int J Technol Assess Health Care. 2007 Fall;23(4):449-54.

PMID:
17937833
11.

Varicella vaccination in Europe: are we ready for a universal childhood programme?

Sengupta N, Booy R, Schmitt HJ, Peltola H, Van-Damme P, Schumacher RF, Campins M, Rodrigo C, Heikkinen T, Seward J, Jumaan A, Finn A, Olcén P, Thiry N, Weil-Olivier C, Breuer J.

Eur J Pediatr. 2008 Jan;167(1):47-55. Epub 2007 Mar 3.

PMID:
17334784
12.

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

Beutels P, Thiry N, Van Damme P.

Vaccine. 2007 Feb 9;25(8):1355-67. Epub 2006 Nov 3. Review.

PMID:
17208339
13.

Economic evaluations of pneumococcal vaccination strategies in adults. A summary of the results.

Thiry N, Beutels P, Van Damme P.

Acta Clin Belg. 2005 Nov-Dec;60(6):338-44. Review.

PMID:
16502594
14.

Recommendations for the use of the 23-valent polysaccharide pneumococcal vaccine in adults: a Belgian consensus report.

Peetermans WE, Van de Vyver N, Van Laethem Y, Van Damme P, Thiry N, Trefois P, Geerts P, Schetgen M, Peleman R, Swennen B, Verhaegen J.

Acta Clin Belg. 2005 Nov-Dec;60(6):329-37. Review.

PMID:
16502593
15.

[Varicella-zoster virus seroprevalence in nursery and day-care workers in Lyon (France)].

Reignier F, Romanò L, Thiry N, Beutels P, Van Damme P, Fau C, Gaspard C, Mamoux V, Zanetti A, Floret D.

Med Mal Infect. 2005 Apr;35(4):192-6. French.

PMID:
15914287
16.

An economic evaluation of varicella vaccination in Italian adolescents.

Thiry N, Beutels P, Tancredi F, Romanò L, Zanetti A, Bonanni P, Gabutti G, Van Damme P.

Vaccine. 2004 Sep 9;22(27-28):3546-62.

PMID:
15315834
17.

Economic evaluations of varicella vaccination programmes: a review of the literature.

Thiry N, Beutels P, Van Damme P, Van Doorslaer E.

Pharmacoeconomics. 2003;21(1):13-38. Review.

PMID:
12484801
18.

The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).

Thiry N, Beutels P, Shkedy Z, Vranckx R, Vandermeulen C, Wielen MV, Damme PV.

Eur J Pediatr. 2002 Nov;161(11):588-93. Epub 2002 Sep 24.

PMID:
12424583
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk